Submitted by Anonymous (not verified) on 10 February 2026 - 13:12
Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 16, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Carvykti, ciltacabtagene autoleucel, Date of authorisation: 25/05/2022, Revision: 16, Status: Authorised